Literature DB >> 23902478

Vascular effects of aldosterone: sorting out the receptors and the ligands.

Ross D Feldman1, Robert Gros.   

Abstract

Aldosterone has actions far beyond its role as a renal regulator of sodium reabsorption, and broader mechanisms of action than simply a transcriptional regulator. Aldosterone has a number of vascular effects, including regulation of vascular reactivity and vascular growth and/or development. Aldosterone-mediated effects on vascular reactivity reflect a balance between its endothelial-dependent vasodilator effects and its direct smooth muscle vasoconstrictor effects. The endothelial vasodilator effects of aldosterone are mediated by phosphatidylinositol 3-kinase-dependent activation of nitric oxide synthase. G-Protein oestrogen receptor (GPER) is a recently recognized G-protein coupled receptor (GPCR) that is activated by steroid hormones. It was first recognized as the GPCR mediating the rapid effects of oestrogens. Activation of GPER also mediates at least some of the vascular effects of aldosterone in smooth muscle and endothelial cells. In vascular endothelial cells, aldosterone activation of GPER mediates vasodilation. In contrast, activation of endothelial mineralocorticoid receptors has been linked to enhanced vasoconstrictor and/or impaired vasodilator responses.
© 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  G-protein oestrogen receptor (GPER); aldosterone; endothelium; mineralocorticoid; smooth muscle; vascular

Mesh:

Substances:

Year:  2013        PMID: 23902478     DOI: 10.1111/1440-1681.12157

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  7 in total

Review 1.  Role of mineralocorticoid receptor antagonists in cardiovascular disease.

Authors:  Carlos M Ferrario; Ernesto L Schiffrin
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

2.  Effects of Treating Primary Aldosteronism on Renal Function.

Authors:  Bart J Kramers; Cornelis Kramers; Jacques W M Lenders; Jaap Deinum
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-23       Impact factor: 3.738

3.  Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.

Authors:  Nathanne S Ferreira; Stêfany B A Cau; Marcondes A B Silva; Carla P Manzato; Fabíola L A C Mestriner; Takayuki Matsumoto; Fernando S Carneiro; Rita C Tostes
Journal:  Front Pharmacol       Date:  2015-03-02       Impact factor: 5.810

Review 4.  Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Authors:  Alessandro Cannavo; Leonardo Bencivenga; Daniela Liccardo; Andrea Elia; Federica Marzano; Giuseppina Gambino; Maria Loreta D'Amico; Claudia Perna; Nicola Ferrara; Giuseppe Rengo; Nazareno Paolocci
Journal:  Oxid Med Cell Longev       Date:  2018-09-19       Impact factor: 6.543

5.  Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist.

Authors:  Qingming Ding; Jozef Chorazyczewski; Robert Gros; Harvey J Motulsky; Lee E Limbird; Ross D Feldman
Journal:  Pharmacol Res Perspect       Date:  2022-10

6.  Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study.

Authors:  Tetsuya Kawahara; Maiko Tsuji; Naoki Tominaga; Nagahiro Toyama; Mikio Toda
Journal:  J Endocr Soc       Date:  2022-08-04

7.  GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.

Authors:  Damiano Cosimo Rigiracciolo; Andrea Scarpelli; Rosamaria Lappano; Assunta Pisano; Maria Francesca Santolla; Silvia Avino; Paola De Marco; Benedetta Bussolati; Marcello Maggiolini; Ernestina Marianna De Francesco
Journal:  Oncotarget       Date:  2016-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.